Posted by bearfan on January 26, 2011, at 15:35:44
In reply to Re: New antidepressant just approved. Vilazodone, posted by Cecilia on January 26, 2011, at 3:16:52
I don't think it's just that simple. Many people can't tolerate Buspar or SSRIs for that matter. The Partial agonist property is what helps prevent the bad side effects like weight gain and sexual dysfunction. There was just a conference with clinical data and investment firms and the folks that developed the drug were glowing with enthusiasm. I am sure they are aware with the clinical trial studies and know the potential of this medication. I have a hunch that Viibryd will be on par with existing SSRIs (with regards to efficacy) but a much less incidence of serious side effects. That being the case, this drug has big potential as a 1st line treatment. Plus there is always augment options for people not getting enough of an effect.
poster:bearfan
thread:977653
URL: http://www.dr-bob.org/babble/20110115/msgs/978023.html